A new study has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing ...

Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that ...

The CHMP recommends conditional marketing authorization for Duvyzat to treat Duchenne muscular dystrophy in patients aged 6 ...

Exosomes are protein-covered messenger cells that trigger all kinds of processes in the body — from wound healing to inflammation. Think of exosomes as a sort of internal post office, sending letters ...

The REVERSE-IT trial showed bentracimab effectively reversed the effects of ticagrelor, restoring platelet function with ...

DelveInsight's " Aplastic Anemia Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth ...

A new clotbusting drug tested on mice has been shown by University of Manchester scientists to be significantly better at ...

A new clotbusting drug tested on mice has been shown by University of Manchester scientists to be significantly better at ...

According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to ...

Novartis raised its 2025 outlook after high demand for key drugs drove first-quarter profit and sales above expectations, becoming the first among peers to lift forecasts this quarter despite looming ...

In the future, this drug could help prevent second heart attacks in patients who are at high risk. It could also lower the ...

Human Platelet Lysate Market is projected to grow significantly through 2035, Driven by demand for stem cell therapy and regenerative medicine ...